Skip to main content
. 2026 Sep 28;14(10):859. doi: 10.3390/vaccines14100859
vNDV velogenic Newcastle Disease Virus
ON Oronasal
CLO Cloacal
SPF specified pathogen-free
Ch Challenge
PFU plaque forming unit
rHVT-ND recombinant herpesvirus of turkeys-vectored Newcastle disease vaccine
PBS phosphate-buffered saline
MDA maternally derived antibodies
EID50 50% Embryo Infective Dose
n.a. not applicable
D day of age
w week of age
SD standard deviation